PharmiWeb.com - Global Pharma News & Resources

Pharmaco - Press Releases

Date Title Company
01-Jun-2023 EVERSANA Forms Strategic Alliance with China Resource Pharmaceutical Commercial Group to Bring New Novel Treatments to Patients Globally EVERSANA
01-Jun-2023 Biotest AG: Biotest presents gigantic artwork to visualize its sustainability initiatives Biotest AG
01-Jun-2023 Astronaut Rayyanah Barnawi concludes KFSH&RC experiments aboard the International Space Station King Faisal Specialist Hospital and Research Center (KFSH&RC)
01-Jun-2023 invoX Pharma increases investment in pHion Therapeutics to further develop next generation of mRNA vaccines invoX Pharma
01-Jun-2023 Simplifying AI Data Analysis for Scientists – as REPROCELL, IBM and STFC Hartree Centre Successfully Launch Pharmacology-AI Platform REPROCELL
01-Jun-2023 Ariceum Therapeutics Expands Pipeline with Acquisition of Theragnostics Ltd Ariceum Therapeutics
01-Jun-2023 BC Platforms Acquires 4Pharma, a Leading International Provider of Medical Research Data and Analytics Services for Global Clinical Trials and Real World Data BC Platforms (BCP)
01-Jun-2023 iOnctura to present research at leading scientific conferences in June 2023 iOnctura
01-Jun-2023 Block Listing Six Monthly Return Spectral MD Holdings, Ltd.
01-Jun-2023 Apogenix AG: Apogenix’ new CD40 agonist HERA-CD40L significantly reduces tumor growth in prostate cancer model Apogenix AG
01-Jun-2023 Simplifying AI Data Analysis for Scientists – as REPROCELL, IBM and STFC Hartree Centre Successfully Launch Pharmacology-AI Platform B3C newswire
01-Jun-2023 Lonza to Acquire Synaffix and Strengthen Antibody-Drug Conjugates Offering Lonza
01-Jun-2023 Information on the total number of voting rights and shares Biosenic
01-Jun-2023 Lonza to Acquire Synaffix and Strengthen Antibody-Drug Conjugates Offering Lonza Group AG
31-May-2023 IGEA Pharma N.V.: IGEA to apply for a further extension of its disclosure obligations IGEA Pharma N.V.
31-May-2023 M1 Kliniken AG publishes Q1 figures 2023: Strong growth and disproportionate increase in operating result M1 Kliniken AG
31-May-2023 HAEMATO AG with a strong start into the year 2023:   Revenue increase of over 25% compared to the same quarter of the previous year and disproportionate increase in the operating result HAEMATO AG
31-May-2023 Evaxion Announces Business Update and First Quarter 2023 Financial Results Evaxion
31-May-2023 Biognosys Launches Spectronaut 18 and Presents Advances in Proteomics Depth, Sensitivity, and Scalability at the ASMS 2023 Annual Conference Biognosys
31-May-2023 Violet Therapeutics raises $10.6 million in seed funding led by the Dementia Discovery Fund (through DDF-2) and co-led by UTEC (University of Tokyo Edge Capital Partners) and Mass General Brigham Ventures (MGBV) Violet Therapeutics